| Primary |
| Blepharitis |
29.1% |
| Eye Infection |
13.8% |
| Dry Eye |
12.1% |
| Conjunctivitis |
6.5% |
| Conjunctivitis Bacterial |
5.4% |
| Infection |
3.7% |
| Meibomian Gland Dysfunction |
3.4% |
| Ocular Rosacea |
3.4% |
| Eye Inflammation |
3.1% |
| Antibiotic Prophylaxis |
2.3% |
| Hordeolum |
2.3% |
| Eye Disorder |
2.0% |
| Keratitis |
2.0% |
| Conjunctivitis Infective |
1.7% |
| Eyelid Infection |
1.7% |
| Glaucoma |
1.7% |
| Meibomianitis |
1.7% |
| Bacterial Infection |
1.4% |
| Eye Irritation |
1.4% |
| Lacrimation Increased |
1.4% |
|
| Product Quality Issue |
39.9% |
| Product Packaging Quantity Issue |
18.2% |
| No Adverse Event |
12.9% |
| Vision Blurred |
3.6% |
| Wrong Technique In Drug Usage Process |
3.3% |
| Inappropriate Schedule Of Drug Administration |
3.0% |
| Off Label Use |
2.8% |
| Underdose |
2.3% |
| Ocular Hyperaemia |
1.9% |
| Overdose |
1.9% |
| Eye Irritation |
1.7% |
| Incorrect Drug Administration Duration |
1.4% |
| Pain |
1.4% |
| Drug Dose Omission |
0.9% |
| Dry Eye |
0.9% |
| Toxic Anterior Segment Syndrome |
0.9% |
| Drug Ineffective |
0.8% |
| Visual Acuity Reduced |
0.8% |
| Visual Impairment |
0.8% |
| Eye Disorder |
0.6% |
|
| Secondary |
| Blepharitis |
28.3% |
| Dry Eye |
17.4% |
| Conjunctivitis |
8.7% |
| Eye Infection |
8.2% |
| Conjunctivitis Bacterial |
4.3% |
| Meibomian Gland Dysfunction |
4.3% |
| Eye Disorder |
2.7% |
| Eye Inflammation |
2.7% |
| Eyelid Infection |
2.7% |
| Meibomianitis |
2.7% |
| Cataract Operation |
2.2% |
| Eye Irritation |
2.2% |
| Keratitis |
2.2% |
| Ocular Rosacea |
2.2% |
| Episcleritis |
1.6% |
| Eye Pruritus |
1.6% |
| Hordeolum |
1.6% |
| Ocular Hyperaemia |
1.6% |
| Rosacea |
1.6% |
| Chalazion |
1.1% |
|
| Product Quality Issue |
33.5% |
| Product Packaging Quantity Issue |
14.3% |
| No Adverse Event |
7.5% |
| Off Label Use |
7.5% |
| Wrong Technique In Drug Usage Process |
5.0% |
| Dry Eye |
3.7% |
| Eye Irritation |
3.7% |
| Inappropriate Schedule Of Drug Administration |
3.1% |
| Vision Blurred |
3.1% |
| Eye Pain |
2.5% |
| Drug Ineffective |
1.9% |
| Pain |
1.9% |
| Product Colour Issue |
1.9% |
| Product Container Issue |
1.9% |
| Underdose |
1.9% |
| Visual Impairment |
1.9% |
| Drug Hypersensitivity |
1.2% |
| Incorrect Drug Administration Duration |
1.2% |
| Ocular Hyperaemia |
1.2% |
| Pemphigus |
1.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
65.5% |
| Dry Eye |
4.0% |
| Rheumatoid Arthritis |
3.4% |
| Pain |
2.8% |
| Cataract Operation |
2.3% |
| Conjunctivitis Bacterial |
2.3% |
| Eye Disorder |
1.7% |
| Glaucoma |
1.7% |
| Hiv Infection |
1.7% |
| Insomnia |
1.7% |
| Psoriasis |
1.7% |
| Psoriatic Arthropathy |
1.7% |
| Rosacea |
1.7% |
| Anxiety |
1.1% |
| Chronic Myeloid Leukaemia |
1.1% |
| Diarrhoea |
1.1% |
| Foreign Body In Eye |
1.1% |
| Hyperlipidaemia |
1.1% |
| Hypertension |
1.1% |
| Intraocular Pressure Increased |
1.1% |
|
| Injection Site Pain |
11.1% |
| Drug Ineffective |
7.4% |
| Interstitial Lung Disease |
7.4% |
| Visual Acuity Reduced |
7.4% |
| Weight Increased |
7.4% |
| Wrong Technique In Drug Usage Process |
7.4% |
| Abdominal Pain |
3.7% |
| Bone Pain |
3.7% |
| Bronchiolitis |
3.7% |
| Cholelithiasis |
3.7% |
| Conjunctivitis Bacterial |
3.7% |
| Death |
3.7% |
| Dizziness |
3.7% |
| Drug Hypersensitivity |
3.7% |
| Hair Disorder |
3.7% |
| Headache |
3.7% |
| Immunodeficiency |
3.7% |
| Inappropriate Schedule Of Drug Administration |
3.7% |
| Incorrect Storage Of Drug |
3.7% |
| Instillation Site Pain |
3.7% |
|
